Literature DB >> 28066593

Diagnostic performance of core needle biopsy in identifying breast phyllodes tumors.

Zhi-Rui Zhou1, Chen-Chen Wang1, Xiang-Jie Sun2, Zhao-Zhi Yang1, Xiao-Li Yu1, Xiao-Mao Guo1.   

Abstract

BACKGROUND: A retrospective analysis of diagnoses was performed in patients with phyllodes tumors of the breast (PTB) who received preoperative core needle biopsy (CNB) and had breast surgery at Fudan University Shanghai Cancer Center from January 1, 2002 to April 1, 2013. The resulting data allowed us to compare the accordance between CNB and excision diagnoses of PTB patients and evaluate the accuracy of CNB in preoperative diagnosis.
METHODS: Data from 128 patients with PTB who had undergone preoperative CNB and breast surgery were retrospectively analyzed. We reviewed the medical history, clinical follow-up data, and CNB diagnostic data. A diagnostic test was used to evaluate the sensitivity and specificity of CNB in diagnosing benign, borderline, and malignant phyllodes tumors.
RESULTS: The accuracy of CNB for diagnosing PTB was 13.3% (17/128). Of the remaining patients, 98 (75.5% of the PTB patients) were diagnosed with fibroadenoma or fibroepithelial lesions. The sensitivity of CNB at diagnosing benign, borderline, and malignant phyllodes tumors were 4.9% (2/41), 4.2% (3/71), and 25.0% (4/16), respectively, whereas the corresponding specificity were 92.0%, 98.2%, and 100%, respectively. Some clinical features, such as large tumor size, rapid growth, or surgical history of fibroadenomas, were indicative of an increased possibility of PTB.
CONCLUSIONS: CNB provides a pathological basis for the preoperative diagnosis of PTB, but it has a poor accuracy and offers limited guidance for surgical decisions. Considering CNB along with multiple histologic features may improve the ability to accurately diagnose PTB. An integrated assessment using CNBs in combination with clinical data and imaging features is suggested as a reliable strategy to assist PTB diagnosis.

Entities:  

Keywords:  Phyllodes tumors of the breast (PTB); core needle biopsy (CNB); diagnostic accuracy

Year:  2016        PMID: 28066593      PMCID: PMC5179415          DOI: 10.21037/jtd.2016.10.109

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  27 in total

1.  Cytological clues in the distinction between phyllodes tumor and fibroadenoma.

Authors:  Imad A El Hag; A Aodah; S M Kollur; A Attallah; A A E Mohamed; H Al-Hussaini
Journal:  Cancer Cytopathol       Date:  2010-02-25       Impact factor: 5.284

2.  Relationship of histologic features to behavior of cystosarcoma phyllodes. Analysis of ninety-four cases.

Authors:  H J Norris; H B Taylor
Journal:  Cancer       Date:  1967-12       Impact factor: 6.860

3.  Phyllodes tumours of the breast - differentiating features in core needle biopsy.

Authors:  Alex K H Tsang; Siu Ki Chan; Christopher C F Lam; Philip C W Lui; Helen H L Chau; Puay Hoon Tan; Gary M Tse
Journal:  Histopathology       Date:  2011-09-14       Impact factor: 5.087

4.  Management of phyllodes breast tumors.

Authors:  Eugenie Guillot; Benoit Couturaud; Fabien Reyal; Alain Curnier; Julie Ravinet; Marick Laé; Marc Bollet; Jean-Yves Pierga; Remy Salmon; Alfred Fitoussi
Journal:  Breast J       Date:  2011-01-19       Impact factor: 2.431

Review 5.  Phyllodes tumours.

Authors:  S J Parker; S A Harries
Journal:  Postgrad Med J       Date:  2001-07       Impact factor: 2.401

6.  Factors associated with phyllodes tumor of the breast after core needle biopsy identifies fibroepithelial neoplasm.

Authors:  Daniel J Gould; Jessica A Salmans; Brian K Lassinger; Alejandro Contreras; Carolina Gutierrez; Elizabeth Bonefas; Kathleen R Liscum; Eric J Silberfein
Journal:  J Surg Res       Date:  2012-04-14       Impact factor: 2.192

7.  Needle core biopsy in the diagnosis of phyllodes neoplasm.

Authors:  Mary F Dillon; Cecily M Quinn; Enda W McDermott; Ann O'Doherty; Niall O'Higgins; Arnold D K Hill
Journal:  Surgery       Date:  2006-11       Impact factor: 3.982

8.  [WHO classification of breast tumors and tumors of the female genital organs: pathology and genetics].

Authors:  W Böcker
Journal:  Verh Dtsch Ges Pathol       Date:  2002

9.  Ultrasonography and core needle biopsy in the differential diagnosis of fibroadenoma and tumor phyllodes.

Authors:  M K Bode; T Rissanen; M Apaja-Sarkkinen
Journal:  Acta Radiol       Date:  2007-09       Impact factor: 1.990

10.  Case for conservative management of selected fibro-adenomas of the breast.

Authors:  P J Cant; M V Madden; P M Close; G M Learmonth; E A Hacking; D M Dent
Journal:  Br J Surg       Date:  1987-09       Impact factor: 6.939

View more
  4 in total

1.  Fibroepithelial Lesions (FELs) of the Breast: Is Routine Excision Always Necessary?

Authors:  Jessica Limberg; Kelly Barker; Syed Hoda; Rache Simmons; Aya Michaels; Jennifer L Marti
Journal:  World J Surg       Date:  2020-05       Impact factor: 3.352

Review 2.  Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).

Authors:  Christoph J Rageth; Elizabeth A M O'Flynn; Katja Pinker; Rahel A Kubik-Huch; Alexander Mundinger; Thomas Decker; Christoph Tausch; Florian Dammann; Pascal A Baltzer; Eva Maria Fallenberg; Maria P Foschini; Sophie Dellas; Michael Knauer; Caroline Malhaire; Martin Sonnenschein; Andreas Boos; Elisabeth Morris; Zsuzsanna Varga
Journal:  Breast Cancer Res Treat       Date:  2018-11-30       Impact factor: 4.872

3.  Core needle biopsy in fibroepithelial tumors: predicting factors for phyllodes tumors.

Authors:  Yedda Nunes Reis; Jonathan Yugo Maesaka; Carlos Shimizu; José Maria Soares-Júnior; Edmund Chada Baracat; José Roberto Filassi
Journal:  Clinics (Sao Paulo)       Date:  2021-04-16       Impact factor: 2.365

4.  Prognostic factors in breast phyllodes tumors: a nomogram based on a retrospective cohort study of 404 patients.

Authors:  Zhi-Rui Zhou; Chen-Chen Wang; Xiang-Jie Sun; Zhao-Zhi Yang; Xing-Xing Chen; Zhi-Ming Shao; Xiao-Li Yu; Xiao-Mao Guo
Journal:  Cancer Med       Date:  2018-02-26       Impact factor: 4.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.